Mind Medicine (MindMed) Inc. announced that it has entered into a share purchase agreements for a concurrent private placement of 12,500,000 common shares at a price of $6 per common share for the gross proceeds of $75,000,000 on March 7, 2024. The transaction is expected to close on or about March 11, 2024, subject to the satisfaction of customary closing conditions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.52 USD | 0.00% | -1.84% | +132.79% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+132.79% | 601M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MNMD Stock
- News Mind Medicine (MindMed) Inc.
- Mind Medicine Inc. announced that it expects to receive $75 million in funding from Deep Track Capital, LP, Commodore Capital